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tomical testing using CTA compared with functional test-
ing among low- to intermediate-risk patients with chest pain 
suspicious for CAD. The primary hypothesis of the study 
was that the clinical outcomes in patients assigned to ana-
tomical testing with the use of CTA would be superior to 
those in patients assigned to functional testing.
A total of 10,003 low- to intermediate-risk patients with 
chest pain (mean age 61 years, 53 % female patients, 21 % 
diabetics) were randomised to evaluation with an ana-
tomical strategy (n = 4996) versus a functional strategy 
(n = 5007). Patients randomised to an anatomical strategy 
underwent a 64-slice CTA, while patients randomised to a 
functional strategy underwent exercise electrocardiography 
(ECG), exercise imaging or pharmacological stress imag-
ing. Among either group who underwent a functional test, 
68 % underwent nuclear stress testing, 22 % underwent 
stress echocardiography and 10 % underwent exercise ECG. 
Duration of follow-up was a median of 25 months.
The primary outcome, all-cause mortality, myocardial 
infarction, hospitalisation for unstable angina, or major 
complication from a cardiovascular procedure occurred in 
3.3 % of the anatomical testing group versus 3.0 % of the 
functional testing group (p = 0.75). Among low- to inter-
mediate-risk patients with chest pain, anatomical testing 
with coronary CTA was not superior to functional testing. 
CTA was associated with an increased frequency of cardiac 
catheterisation; however, it was associated with a lower fre-
quency of invasive catheterisation showing non-obstructive 
CAD. Anatomical testing was also associated with increased 
radiation exposure and a non-significant increase in total 
costs. In conclusion, in symptomatic patients with suspected 
CAD who required non-invasive testing, an initial strategy 
of CTA was not associated with better clinical outcomes 
than functional testing over a median follow-up of 2 years.
Over the years, considerable debate has arisen whether a 
pure anatomical test would suffice to demonstrate the sig-
nificance of coronary artery disease (CAD) in patients 
suspected for CAD, and–more importantly–whether this 
anatomical information would have a bearing on clinical 
outcome [1, 2]. In particular, coronary computed tomogra-
phy angiography (CTA) has been put forward as an opti-
mal non-invasive anatomical imaging test to detect CAD 
in patients with stable CAD [3]. A number of studies has 
shown that CTA has a high sensitivity, reasonable specific-
ity and an extremely high negative predictive value [4–10]. 
Several large-scale studies have shown that a strategy of 
CTA use in the emergency department is associated with 
faster discharge, as compared with standard care, without a 
significant difference in event rates [11–13]. However, the 
lack of evidence supporting CTA in randomised trials has 
also been mentioned. As a consequence, the relative impact 
of data from non-invasive anatomical testing versus func-
tional testing on subsequent management and clinical out-
comes is not fully known.
At the recently held conference of the American College 
of Cardiology (ACC), San Diego, California, 14–18 March 
2015, the Prospective Multicenter Imaging Study for Evalu-
ation of Chest Pain (PROMISE) trial was presented by 
Pamela S. Douglas, MD (Duke University School of Medi-
cine, Durham, North Carolina, USA) and simultaneously 
published online in The New England Journal of Medicine 
[14]. The goal of the PROMISE trial was to evaluate ana-
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Simply stated, the PROMISE study suggests therefore 
that patients, suspected for CAD and undergoing CTA, do 
not have less risk of heart attack, dying or being hospitalised 
months later than those who take a simple treadmill test or 
other functional test. According to W. Douglas Weaver, MD, 
former president of the ACC, these findings should temper 
the enthusiastic use of CTA to screen patients with chest 
pain–it is not worth the added radiation and use of unneces-
sary heart catheterisations and stent implantations, which did 
nothing to improve the outcome of patients. Valentin Fuster, 
MD, current editor-in-chief of the Journal of the American 
College of Cardiology questioned if there could be a long-
term benefit in direct visualisation using CTA. The study 
author, Pamela S. Douglas, said the research group plans 
to further investigate outcomes for different subgroups of 
patients to determine whether different groups might ben-
efit from different testing approaches. In an accompanying 
Editorial [15], it was stated that the International Study of 
Comparative Health Effectiveness with Medical and Inva-
sive Approaches (ISCHEMIA; ClinicalTrials.gov number, 
NCT01471522), in which randomised therapy (invasive 
versus medical, which is driven by the presence of extensive 
ischaemia on functional stress testing), will help answer this 
question.
So far, the PROMISE trial offers clear promise that func-
tional stress testing provides at least similar information to 
CTA and–for economical and safety reasons–might prevail 
over CTA alone in patients with suspected CAD.
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